SPX4,297.14+16.99 0.40%
DIA339.37+1.54 0.46%
IXIC13,128.05+80.87 0.62%

--Oppenheimer Adjusts Integra LifeSciences Holdings Price Target to $70 From $78, Maintains Outperform Rating

--Oppenheimer Adjusts Integra LifeSciences Holdings Price Target to $70 From $78, Maintains Outperform Rating

MT Newswires · 07/28/2022 07:06

Please log in to view news